🔥🐔 BizChicken 🐔🔥
Companies Similar to Tekla Life Sciences Investors
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
The GDL Fund
Closed-ended equity mutual fund
The GDL Fund is a closed-ended equity mutual fund managed by Gabelli Funds, LLC, investing globally in public equity markets primarily focusing on mergers, takeovers, and corporate reorganizations.
Symbol: GDL
Recent Price: $8.02
Industry: Asset Management
CEO: Mr. Mario Joseph Gabelli C.F.A.
Sector: Financial Services
Employees: N/A
Address: One Corporate Center, Rye, NY 10580-1422
Phone: 914-921-5000
Last updated: 2024-12-31
Tekla Life Sciences Investors
Closed-ended equity mutual fund
Tekla Life Sciences Investors is a closed-ended equity mutual fund that invests in public equity markets globally, focusing on the life sciences sector, including biotechnology, pharmaceuticals, and healthcare industries. The fund emphasizes growth stocks of small cap companies, using fundamental analysis for investment decisions.
Symbol: HQL
Recent Price: $13.14
Industry: Asset Management
CEO: Dr. Daniel R. Omstead M.S, Ph.D.
Sector: Financial Services
Employees: N/A
Address: 100 Federal Street, Boston, MA 02110
Phone: 617 772 8500
Last updated: 2024-12-31
Tortoise Energy Independence Fund, Inc.
Tortoise Energy Independence Fund
Tortoise Energy Independence Fund, Inc. is a closed-ended equity mutual fund investing in the North American public equity markets, focusing primarily on the energy sector. Managed by Tortoise Capital Advisors L.L.C., the fund employs a bottom-up stock picking approach using various analysis factors.
About | About | News | Contact | About | Careers | About | About | About | About | Careers | Careers | About
Symbol: NDP
Recent Price: $40.40
Industry: Asset Management
CEO: Mr. Terry Clyde Matlack CFA, J.D.
Sector: Financial Services
Employees: N/A
Address: 6363 College Boulevard, Overland Park, KS 66211-1938
Phone: 913 981 1020
Last updated: 2024-12-31
The China Fund, Inc.
Equity Mutual Fund
The China Fund, Inc. is a closed ended equity mutual fund managed by Allianz Global Investors U.S. LLC, investing in public equity markets in China, Hong Kong, and Taiwan with a combination of fundamental and quantitative analyses.
Symbol: CHN
Recent Price: $11.95
Industry: Asset Management
CEO: N/A
Sector: Financial Services
Employees: N/A
Address: 1633 Broadway, New York, NY 10019
Phone: 212 739 3000
Last updated: 2024-12-31
Integra LifeSciences Holdings Corporation
surgical implants and medical instruments
Integra Life Sciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for neurosurgery, extremity reconstruction, and general surgery. It operates in segments such as Codman Specialty Surgical and Tissue Technologies, offering a range of products including neurosurgery equipment and regenerative technology for wound treatment.
Symbol: IART
Recent Price: $22.47
Industry: Medical - Devices
CEO: Mr. Jan De Witte
Sector: Healthcare
Employees: 3946
Address: 1100 Campus Road, Princeton, NJ 08540
Phone: 609 275 0500
Last updated: 2024-12-31
Calamos Global Total Return Fund
Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-ended balanced mutual fund managed by Calamos Advisors LLC, investing in global public equity and fixed income markets, focusing on diversified sector securities.
About | About | About | Sustainability | News | Locations | Contact | Careers | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | Benefits | About | About | About | About | About
Symbol: CGO
Recent Price: $11.45
Industry: Asset Management - Global
CEO: Mr. John Peter Calamos Sr.
Sector: Financial Services
Employees: N/A
Address: 2020 Calamos Court, Naperville, IL 60563-2787
Phone: 630-245-7200
Last updated: 2024-12-31
Telomir Pharmaceuticals, Inc. Common Stock
TELOMIR-1
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on developing and commercializing therapies for age-related inflammatory conditions and post-chemotherapy recovery.
Symbol: TELO
Recent Price: $4.64
Industry: Biotechnology
CEO: Mr. Erez Aminov
Sector: Healthcare
Employees: 1
Address: 855 N Wolfe Street, Baltimore, null 21205
Phone: (737)-289-0835
Last updated: 2024-12-31
Eagle Point Credit Company Inc.
Closed Ended Fund
Eagle Point Credit Company Inc. is a closed ended fund, investing in fixed income markets of the U.S. with a focus on equity and junior debt tranches of collateralized loan obligations.
Symbol: ECC
Recent Price: $9.70
Industry: Asset Management
CEO: Mr. Thomas Philip Majewski CPA
Sector: Financial Services
Employees: N/A
Address: 20 Horseneck Lane, Greenwich, CT 06830
Phone: 12038623150
Last updated: 2024-11-08
Cohen & Steers Closed-End Opportunity Fund, Inc.
Cohen & Steers Closed-End Opportunity Fund, Inc.
Cohen & Steers Closed-End Opportunity Fund, Inc. is a close-ended fund of funds launched by Cohen & Steers Inc., focusing on investments in diverse equity markets and income-oriented strategies.
About | Contact | About | About | About | About | About | Careers | Careers | About | About | About | About
Symbol: FOF
Recent Price: $12.64
Industry: Asset Management
CEO: Mr. Robert Hamilton Steers
Sector: Financial Services
Employees: 0
Address: 280 Park Avenue, New York, NY 10017-1216
Phone: 212 832 3232
Last updated: 2024-12-31
The Gabelli Equity Trust Inc.
Gabelli Equity Trust
The Gabelli Equity Trust Inc. is a closed ended equity mutual fund launched by GAMCO Investors, Inc., managed by Gabelli Funds, LLC, investing in value stocks across diversified sectors in the U.S.
Symbol: GAB
Recent Price: $5.38
Industry: Asset Management
CEO: Mr. Carter W. Austin
Sector: Financial Services
Employees: N/A
Address: One Corporate Center, Rye, NY 10580-1422
Phone: 914-921-5000
Last updated: 2024-12-31
Guggenheim Strategic Opportunities Fund
Mutual Fund
Guggenheim Strategic Opportunities Fund is a closed-ended balanced mutual fund investing in global public equity and fixed income markets, managed by Guggenheim Funds Investment Advisors, LLC and co-managed by Guggenheim Partners Investment Management LLC.
Symbol: GOF
Recent Price: $15.25
Industry: Asset Management
CEO: Mr. Donald Christopher Cacciapaglia
Sector: Financial Services
Employees: N/A
Address: 227 West Monroe Street, Chicago, IL 60606
Phone: 312-827-0100
Last updated: 2024-12-31
Tekla Healthcare Investors
Equity Mutual Fund
Tekla Healthcare Investors is a closed-ended equity mutual fund managed by Tekla Capital Management LLC, investing in public equity markets globally, focused on the healthcare sector including biotechnology, medical devices, and pharmaceuticals.
Symbol: HQH
Recent Price: $16.19
Industry: Asset Management
CEO: Dr. Daniel R. Omstead M.S, Ph.D.
Sector: Financial Services
Employees: N/A
Address: 100 Federal Street, Boston, MA 02110
Phone: 617 772 8500
Last updated: 2024-12-31
MFS Multimarket Income Trust
MFS Multimarket Income Trust
MFS Multimarket Income Trust is a closed ended fixed income mutual fund that invests in global fixed income markets, emphasizing U.S. securities, using a fundamental analysis approach.
About | About | About | About | History | About | News | About | Contact | Careers | Careers | Jobs | Jobs | Jobs | DEI | About | About | About | About
Symbol: MMT
Recent Price: $4.79
Industry: Asset Management - Income
CEO: Ms. Robin Ann Stelmach
Sector: Financial Services
Employees: N/A
Address: 111 Huntington Avenue, Boston, MA 02199
Phone: 617 954 5000
Last updated: 2024-11-08
Tortoise Midstream Energy Fund, Inc.
Tortoise MLP Fund
Tortoise MLP Fund, Inc. is a closed-end equity mutual fund managed by Tortoise Capital Advisors L.L.C, focusing on equity securities of MLPs in the natural gas infrastructure sector.
About | About | News | Contact | About | Careers | About | About | About | About | About | Careers | About
Symbol: NTG
Recent Price: $53.36
Industry: Asset Management
CEO: Mr. Terry Clyde Matlack CFA, J.D.
Sector: Financial Services
Employees: N/A
Address: 6363 College Boulevard, Overland Park, KS 66211-1938
Phone: 913 981 1020
Last updated: 2024-12-31
Columbia Seligman Premium Technology Growth Fund
N/A
Columbia Seligman Premium Technology Growth Fund is a closed ended equity mutual fund launched and managed by Columbia Management Investment Advisers, LLC. It invests in public equity markets. The fund seeks to invest in stocks of companies operating in the technology sector. It primarily invests in growth stocks of companies. It employs fundamental analysis with focus on factors like companies that have best growth prospects, trade at attractive valuations and deliver solid investment returns over time to create its portfolio. The fund benchmarks the performance of its portfolio against the S&P North American Technology Sector Index. The fund was formerly known as Seligman Premium Technology Growth Fund, Inc. Columbia Seligman Premium Technology Growth Fund was formed on November 30, 2009 and is domiciled in the United States.
No tags available.
About | Contact | About | Leadership | About | DEI | News | DEI | Contact | Contact | Careers | Careers | About | About | About
Symbol: STK
Recent Price: $32.06
Industry: Asset Management
CEO: Mr. William Frederick Truscott
Sector: Financial Services
Employees: N/A
Address: 290 Congress Street, Boston, MA 02210
Phone: 800 225 2365
Leadership
- William F. "Ted" Truscott, Chief Executive Officer
- Daniel Beckman, CFA, President and Trustee, Columbia Funds
- Stewart Bennett, Global Head of Alternatives
- William Davies, Global Chief Investment Officer
- David Logan, Head of EMEA and Global Business Operations
- Leslie Walstrom, Global Head of Marketing
- Marc Zeitoun, CFA, Head of North America Product and Business Intelligence Investments
- Joshua Kutin, CFA, Head of Asset Allocation, North America
- Jay Leopold, CFA, Global Head of Investment Risk Management
- Melda Mergen, CFA, CAIA, Global Head of Equities
- Kirk Moore, CFA, Global Head of Research
- Tony Sandhu, Global Head of Investment Consultancy and Oversight
- Gene Tannuzzo, CFA, Global Head of Fixed Income Distribution
- James Bumpus, CIMA, Head of Intermediary Markets
- Thomas Jones, Head of Strategic Relations
Last updated: 2024-12-31
Tekla Healthcare Opportunities Fund
N/A
Tekla Healthcare Opportunities Fund is a closed ended balanced mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating in the healthcare sector. The fund also invests in pooled investment vehicles. For its fixed income portion, the fund invests in corporate debt securities across the credit rating spectrum. It benchmarks the performance of its portfolio against the S&P 1500 Healthcare Index and S&P 500 Index. Tekla Healthcare Opportunities Fund was formed on April 2, 2014 and is domiciled in the United States.
No tags available.
Symbol: THQ
Recent Price: $18.95
Industry: Asset Management
CEO: Dr. Daniel R. Omstead M.S, Ph.D.
Sector: Financial Services
Employees: N/A
Address: 100 Federal Street, Boston, MA 02110
Phone: 617 772 8500
Last updated: 2024-12-31
Tekla World Healthcare Fund
N/A
Tekla World Healthcare Fund is a closed-ended balanced mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector. For its fixed income portion, the fund primarily invests in corporate debt securities. Tekla World Healthcare Fund was formed on June 26, 2015 and is domiciled in the United States.
No tags available.
Symbol: THW
Recent Price: $11.05
Industry: Asset Management
CEO: Mr. William R. Hite C.F.A.
Sector: Financial Services
Employees: N/A
Address: 100 Federal Street, Boston, MA 02110
Phone: 617 772 8500
Last updated: 2024-12-31
Kezar Life Sciences, Inc.
KZR-616
Kezar Life Sciences is a clinical-stage biotechnology company focused on developing novel small molecule therapeutics to address unmet needs in immune-mediated diseases and cancer in the United States.
About | About | About | About | Directors | About | Contact | Contact | Careers | Careers | Careers | Leadership | About | About | About | About | About | About | About | News | About | Careers | Contact | Careers | Careers | Careers | About | About | About | About
Symbol: KZR
Recent Price: $6.82
Industry: Biotechnology
CEO: Dr. Christopher J. Kirk Ph.D.
Sector: Healthcare
Employees: 58
Address: 4000 Shoreline Court, South San Francisco, CA 94080
Phone: 650 822 5600
Leadership
- Christopher Kirk, PhD, Chief Executive Officer, Co-Founder
- Marc Belsky, Chief Financial Officer
- Mark Schiller, Chief Legal Officer
- Neel K. Anand, DPhil, SVP, Research and Drug Discovery
- Zung To, SVP, Clinical Development
- Gitanjali Jain, SVP, Investor Relations and External Affairs
- Michelle Greenman, VP, Global Regulatory Affairs
- Jim Kirchner, PhD, VP, CMC and Supply Chain
- Andrew Basham, VP, Legal Affairs
- Dave Braggs, VP, Quality Assurance
- Pattie Chiang, SVP, Corporate Controller
- Tony Muchamuel, VP, Pharmacology & Toxicology
- Kiruthi Palaniswamy, PharmD, VP, Medical Affairs
- Mary Rogers, VP, Financial Planning & Analysis
- Joe Tedrick, VP, Human Resources
- Jinhai Wang, PhD, VP, Drug Metabolism & Pharmacokinetics
- John Fowler, Co-Founder
- Graham Cooper, Board Member, Beam Therapeutics, Former CFO, Receptos
- Franklin Berger, Founder
- Elizabeth Garner, MD, MPH, Chief Science Officer
- Michael Kauffman, MD, PhD, President, Chief Executive Officer, and Director
- Micki Klearman, MD, Former Group Medical Director
- Courtney Wallace, Venture Partner
Last updated: 2024-12-31
Bio-Techne Corporation
Life Science Reagents, Instruments, and Services
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for research and clinical diagnostics globally, operating through segments like Protein Sciences and Diagnostics and Genomics.
About | ESG | Events | About | About | Contact | Careers | About | About | About | About | About
Symbol: TECH
Recent Price: $72.29
Industry: Biotechnology
CEO: Mr. Kim Kelderman
Sector: Healthcare
Employees: 3100
Address: 614 McKinley Place N.E., Minneapolis, MN 55413
Phone: 612 379 8854
Last updated: 2024-12-31
Thermo Fisher Scientific Inc.
Life Sciences Solutions
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services worldwide, supporting various sectors including pharmaceuticals, biotechnology, and clinical research.
About | Events | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Site Map | Jobs | Jobs | About
Symbol: TMO
Recent Price: $518.84
Industry: Medical - Diagnostics & Research
CEO: Mr. Marc N. Casper
Sector: Healthcare
Employees: 122000
Address: 168 Third Avenue, Waltham, MA 02451
Phone: 781 622 1000
Last updated: 2024-12-31